Design and synthesis of 1,3-diarylurea derivatives as selective cyclooxygenase (COX-2) inhibitors

被引:28
作者
Zarghi, Afshin [1 ]
Kakhgi, Samaneh [1 ]
Hadipoor, Atefeh [1 ]
Daraee, Bahram [2 ]
Dadrass, Orkideh G. [3 ]
Hedayati, Mehdi [4 ]
机构
[1] Shahid Beheshti Univ Med Sci, Dept Pharmaceut Chem, Sch Pharm, Tehran, Iran
[2] Tarbiat Modares Univ, Tehran, Iran
[3] Azad Univ, Sch Pharm, Tehran, Iran
[4] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Tehran, Iran
关键词
1,3-diarylurea; COX-2; inhibition; SAR;
D O I
10.1016/j.bmcl.2008.01.021
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A group of 1,3-diarylurea derivatives, possessing a methylsulfonyl pharmacophore at the para-position of the N-1 phenyl ring, in conjunction with a N-3 substituted-phenyl ring (4-F, 4-Cl, 4-Me, 4-OMe), were designed and synthesized for evaluation as selective cyclooxygenase-2 (COX-2) inhibitors. In vitro COX-1/COX-2 isozyme inhibition structure - activity studies identified 1-(4methylsulfonylphenyl)-3-(4- methoxyphenyl) urea (4e) as a potent COX-2 inhibitor (IC50 = 0.11 mu M) with a high COX-2 selectivity index ( SI = 203.6) comparable to the reference drug celecoxib (COX-2 IC50 = 0.06 mu M; COX-2 SI =405). The structure - activity data acquired indicate that the urea moiety constitutes a suitable scaffold to design new acyclic 1,3-diarylurea derivatives with selective COX-2 inhibitory activity. (c) 2008 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1336 / 1339
页数:4
相关论文
共 50 条
  • [41] Design and synthesis of new 1,2-diaryl-4,5,6,7-tetrahydro-1H-benzo[d] imidazoles as selective cyclooxygenase (COX-2) inhibitors
    Zarghi, A.
    Reihanfard, H.
    Arfaei, S.
    Daraei, B.
    Hedayati, M.
    MEDICINAL CHEMISTRY RESEARCH, 2012, 21 (08) : 1869 - 1875
  • [42] 2D QSAR STUDY OF INDOLE DERIVATIVES AS SELECTIVE COX-2 INHIBITORS
    Chavan, R. S.
    More, H. N.
    Bhosale, A., V
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH, 2019, 10 (07): : 3378 - 3385
  • [43] Synthesis and evaluation of fluorobenzoylated di- and tripeptides as inhibitors of cyclooxygenase-2 (COX-2)
    Sharma, Sai Kiran
    Al-Hourani, Baker Jawabrah
    Wuest, Melinda
    Mane, Jonathan Y.
    Tuszynski, Jack
    Baracos, Vickie
    Suresh, Mavanur
    Wuest, Frank
    BIOORGANIC & MEDICINAL CHEMISTRY, 2012, 20 (07) : 2221 - 2226
  • [44] Selective COX-2 inhibitors: potentials and limits
    Pairet, M
    Netter, P
    THERAPIE, 1999, 54 (04): : 433 - 445
  • [45] QSAR analysis of 1,3-diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives as selective COX-2 inhibitors
    Silakari, Pratigya
    Shrivastava, Savitri Devi
    Silakari, Gyati
    Kohli, Dharm Veer
    Rambabu, Gundla
    Srivastava, Soumya
    Shrivastava, Santosh Kumar
    Silakari, Om
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2008, 43 (07) : 1559 - 1569
  • [46] Design, synthesis, and biological evaluation of new 1,4-diarylazetidin-2-one derivatives (β-lactams) as selective cyclooxygenase-2 inhibitors
    Arefi, Hadi
    Naderi, Nima
    Shemirani, Amir B. Irani
    Falavarjani, Mina Kiani
    Movahed, Mahsa Azami
    Zarghi, Afshin
    ARCHIV DER PHARMAZIE, 2020, 353 (03)
  • [47] Design and synthesis of new rofecoxib analogs as selective cyclooxygenase-2(COX-2) inhibitors:: Replacement of the methanesulfonyl pharmacophore by an N-acetylsulfonamido bioisostere.
    Zarghi, Afshin
    Rao, P. N. Praveen
    Knaus, Edward E.
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2007, 10 (02): : 159 - 167
  • [48] Selective cyclooxygenase-2 (COX-2) inhibition reduces proteinuria in renal patients
    Vogt, Liffert
    de Zeeuw, Dick
    Woittiez, Arend Jan J.
    Navis, Gerjan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (04) : 1182 - 1189
  • [49] Design of a heteroaryl modified, 1,5-disubstituted pyrazole cyclooxygenase-2 (COX-2) selective inhibitor
    Ezawa, M
    Garvey, DS
    Janero, DR
    Khanapure, SP
    Letts, LG
    Martino, A
    Ranatunge, RR
    Schwalb, DJ
    Young, DV
    LETTERS IN DRUG DESIGN & DISCOVERY, 2005, 2 (01) : 40 - 43
  • [50] Design and synthesis of pyrazole-pyrazoline hybrids as cancer-associated selective COX-2 inhibitors
    Akhtar, Wasim
    Marella, Akranth
    Alam, Mohammad Mumtaz
    Khan, Mohemmed F.
    Akhtar, Mymoona
    Anwer, Tariq
    Khan, Farah
    Naematullah, Md.
    Azam, Faizul
    Rizvi, Moshahid A.
    Shaquiquzzaman, Mohammad
    ARCHIV DER PHARMAZIE, 2021, 354 (01)